This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2002 Sep;23(9):435-6; author reply 436-7.

doi: 10.1016/s1471-4906(02)02290-1.

Adoptive transfer of T-cell immunity: gene transfer with MHC-restricted receptors

Reno Debets, Ralph Willemsen, Reinder Bolhuis

PMID: 12200063
DOI: 10.1016/s1471-4906(02)02290-1

Comment

Adoptive transfer of T-cell immunity: gene transfer with MHC-restricted receptors

Reno Debets et al. Trends Immunol. 2002 Sep.

. 2002 Sep;23(9):435-6; author reply 436-7.

doi: 10.1016/s1471-4906(02)02290-1.

Authors

Reno Debets, Ralph Willemsen, Reinder Bolhuis

PMID: 12200063
DOI: 10.1016/s1471-4906(02)02290-1

No abstract available

PubMed Disclaimer

Comment on

Adoptive transfer of T-cell immunity.
Kessels HW, Wolkers MC, Schumacher TN. Kessels HW, et al. Trends Immunol. 2002 May;23(5):264-9. doi: 10.1016/s1471-4906(02)02219-6. Trends Immunol. 2002. PMID: 12102748 Review. No abstract available.

Similar articles

T cell retargeting with MHC class I-restricted antibodies: the CD28 costimulatory domain enhances antigen-specific cytotoxicity and cytokine production.
Willemsen RA, Ronteltap C, Chames P, Debets R, Bolhuis RL. Willemsen RA, et al. J Immunol. 2005 Jun 15;174(12):7853-8. doi: 10.4049/jimmunol.174.12.7853. J Immunol. 2005. PMID: 15944290
TCR-like human antibodies expressed on human CTLs mediate antibody affinity-dependent cytolytic activity.
Chames P, Willemsen RA, Rojas G, Dieckmann D, Rem L, Schuler G, Bolhuis RL, Hoogenboom HR. Chames P, et al. J Immunol. 2002 Jul 15;169(2):1110-8. doi: 10.4049/jimmunol.169.2.1110. J Immunol. 2002. PMID: 12097420
Adenovirus targeting to HLA-A1/MAGE-A1-positive tumor cells by fusing a single-chain T-cell receptor with minor capsid protein IX.
de Vrij J, Uil TG, van den Hengel SK, Cramer SJ, Koppers-Lalic D, Verweij MC, Wiertz EJ, Vellinga J, Willemsen RA, Hoeben RC. de Vrij J, et al. Gene Ther. 2008 Jul;15(13):978-89. doi: 10.1038/gt.2008.26. Epub 2008 Mar 6. Gene Ther. 2008. PMID: 18323790
Moving from tinkering in the garage to assembly line production: the manufacture of genetically modified T cells expressing chimeric antigen receptors (CARs) comes on line.
Cooper LJ. Cooper LJ. Cancer Gene Ther. 2015 Mar;22(2):64-6. doi: 10.1038/cgt.2014.70. Epub 2015 Feb 13. Cancer Gene Ther. 2015. PMID: 25675874 Review. No abstract available.
Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo.
Pape KA, Kearney ER, Khoruts A, Mondino A, Merica R, Chen ZM, Ingulli E, White J, Johnson JG, Jenkins MK. Pape KA, et al. Immunol Rev. 1997 Apr;156:67-78. doi: 10.1111/j.1600-065x.1997.tb00959.x. Immunol Rev. 1997. PMID: 9176700 Review.

See all similar articles

Cited by

Harnessing Cellular Immunotherapy for EBV-Associated Malignancies: Current Advances and Future Directions.
Gao Y, Wang D, Li C. Gao Y, et al. J Cell Mol Med. 2025 May;29(10):e70603. doi: 10.1111/jcmm.70603. J Cell Mol Med. 2025. PMID: 40401927 Free PMC article. Review.
Adoptive transfer of genetically modified Wilms' tumor 1-specific T cells in a novel malignant skull base meningioma model.
Iwami K, Natsume A, Ohno M, Ikeda H, Mineno J, Nukaya I, Okamoto S, Fujiwara H, Yasukawa M, Shiku H, Wakabayashi T. Iwami K, et al. Neuro Oncol. 2013 Jun;15(6):747-58. doi: 10.1093/neuonc/not007. Epub 2013 Mar 3. Neuro Oncol. 2013. PMID: 23460320 Free PMC article.
A new way to generate cytolytic tumor-specific T cells: electroporation of RNA coding for a T cell receptor into T lymphocytes.
Schaft N, Dörrie J, Müller I, Beck V, Baumann S, Schunder T, Kämpgen E, Schuler G. Schaft N, et al. Cancer Immunol Immunother. 2006 Sep;55(9):1132-41. doi: 10.1007/s00262-005-0098-2. Epub 2005 Dec 13. Cancer Immunol Immunother. 2006. PMID: 16344988 Free PMC article.
mRNA as novel technology for passive immunotherapy.
Schlake T, Thess A, Thran M, Jordan I. Schlake T, et al. Cell Mol Life Sci. 2019 Jan;76(2):301-328. doi: 10.1007/s00018-018-2935-4. Epub 2018 Oct 17. Cell Mol Life Sci. 2019. PMID: 30334070 Free PMC article. Review.
RNA-transfection of γ/δ T cells with a chimeric antigen receptor or an α/β T-cell receptor: a safer alternative to genetically engineered α/β T cells for the immunotherapy of melanoma.
Harrer DC, Simon B, Fujii SI, Shimizu K, Uslu U, Schuler G, Gerer KF, Hoyer S, Dörrie J, Schaft N. Harrer DC, et al. BMC Cancer. 2017 Aug 17;17(1):551. doi: 10.1186/s12885-017-3539-3. BMC Cancer. 2017. PMID: 28818060 Free PMC article.

Publication types

Actions
Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions
Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
Other Literature Sources
- The Lens - Patent Citations Database
Research Materials
- NCI CPTC Antibody Characterization Program